The Harvard Drug Group, L.L.C.
Dublin, OH Doing business as First Veterinary Supply Major Pharmaceuticals & Rugby Laboratories Part of Generic Drug Holdings LLC
- UEI
- CBGGKKVNJBK9
- CAGE
- 1LEZ0
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Cardinal Health, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Other
- Corporate family
-
-
Parent
Livonia, MI
FQ9FKRL82FR6
-
Parent
Livonia, MI
FQ9FKRL82FR6
- SAM.gov registration date
- Physical address
- 7000 Cardinal Pl, Dublin, OH 43017, USA
- Website
- majorpharmaceuticals.com
- Founded
- 1971
- Employees
- 11-50
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $8,303 |
| FY2025 | $86,993 |
| FY2024 | $76,538 |
| FY2023 | $42,756 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Logistics Agency | $8,303 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cardinal Health Specialty Pharmaceutical Distribution | Dublin, OH | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Hygen Pharmaceuticals Inc. | Redmond, WA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Corporate Office | Conshohocken, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Prasco, LLC | Mason, OH | 325412 Pharmaceutical Preparation Manufacturing |
About the company
The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division, doing business as First Veterinary Supply, is a Native Hawaiian Organization-owned pharmaceutical manufacturer and distributor operating as a prime contractor (100% of its awards) supplying over-the-counter and prescription medications, generic drugs, and hematology-related products to the federal government. The vendor is a subsidiary of Cardinal Health, Inc. headquartered in La Vergne, Tennessee, and competes full-and-open without set-aside designation across its entire federal portfolio.
The Harvard Drug Group's federal customer base is heavily concentrated in defense and veterans healthcare. The Defense Logistics Agency Troop Support Medical dominates by award volume at 5,066 delivery orders (97% of award count) worth $36.9 million combined potential value, reflecting routine, small-value pharmaceutical supply orders with completion windows of one to two days. However, the Department of Veterans Affairs controls the dollar value: the VA's Veterans Integrated Service Network 12 (VISN 12) anchors $1.06 billion in combined potential value across nine awards, while the VA's National Acquisition Center carries $137 million across nine awards. The distinction signals a structural split — DLA places thousands of tactical resupply orders, while VA awards represent strategic supply agreements. Together, these three VA and DLA customer lines account for 100% of combined potential value. The Health Resources and Services Administration's National Hansen's Disease Program Clinical Research Center and VA's VISN 15 round out active customers at negligible scale.
The Harvard Drug Group holds a multi-year Federal Supply Schedule contract under GSA's Pharmaceuticals and Drugs schedule (FSS 65 I B), awarded June 1, 2025, with a ceiling of $420.1 million through May 31, 2030, and funded by VA's VISN 12. This vehicle anchors the vendor's strategic position in federal pharmaceutical supply. The company also places delivery orders against two primary Indefinite Delivery Contracts — SPE2D019D0002 (3,643 task orders, $344 thousand combined potential value) and SPM2D008D0255 (1,406 task orders, $692 thousand combined potential value), which generate the bulk of DLA Medical Supply Chain activity. Representative recent work includes delivery orders for acetaminophen 500 mg tablets (1,000 count) at $1,298.88 (February 2, 2026), mucus relief ER 600 mg tablets (500 count) at $1,084.50 (September 19, 2025), and ibuprofen 800 mg tablets at prices ranging from $15 to $664 per order (September 2025 batch).
Activity shows year-over-year growth through 2025 — from 551 awards in 2022 to 751 in 2025 — driven entirely by the high-volume DLA Medical Supply Chain delivery-order stream. The vendor carries $1.24 billion in combined potential value across 5,335 total awards but has obligated only $2.5 million to date (0% of potential), a pattern consistent with indefinite delivery vehicles with large ceilings and incremental task-order utilization. The NAICS and PSC profile confirms pharmaceutical focus: 5,058 awards under Medicinal and Botanical Manufacturing and 5,265 under Drugs And Biologicals PSC. The vendor operates entirely as a prime contractor with no subcontract footprint. Place of performance is concentrated at La Vergne, Tennessee, with nationwide distribution capability across the Veterans Integrated Service Network.
Quick answers
Is The Harvard Drug Group, L.L.C. registered in SAM.gov?
Yes. The Harvard Drug Group, L.L.C.'s SAM.gov registration is active through June 3, 2027.
Which contract vehicles does The Harvard Drug Group, L.L.C. hold?
The Harvard Drug Group, L.L.C. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has The Harvard Drug Group, L.L.C. received in federal contracts?
Federal contracts obligated $86,993 to The Harvard Drug Group, L.L.C. in fiscal year 2025 and $214,590 in fiscal years 2023 through 2027.
How does The Harvard Drug Group, L.L.C. rank among federal contractors?
The Harvard Drug Group, L.L.C.'s parent company, Cardinal Health, Inc., ranked #4 in NAICS 325411, #17 in NAICS 3254 and #17 in PSC 6505 in FY2025.
What is The Harvard Drug Group, L.L.C.'s most recent federal award?
The Harvard Drug Group, L.L.C.'s most recent federal contract award is Cetirizine HCL 10 MG tablet 100S (SPE2D326F259J), from Medical Supply Chain (DLA), on July 14, 2026.
On GovTribe
See The Harvard Drug Group, L.L.C.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors